Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

PERFECT SHAPE MEDICAL LIMITED

必 瘦 站 醫 學 美 容 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 1830)

VOLUNTARY ANNOUNCEMENT

FURTHER INCREASE IN SHAREHOLDING IN THE COMPANY

BY THE CHAIRMAN, CHIEF EXECUTIVE OFFICER AND

EXECUTIVE DIRECTOR

This is a voluntary announcement made by the board of directors (the "Board") of Perfect Shape Medical Limited (the "Company") in relation to the further increase in the holding of shares in the Company ("Shares") by Dr. Au-Yeung Kong ("Dr. Au-Yeung"), the chairman, chief executive officer and executive director of the Company.

The Board was informed that Dr. Au-Yeung had further purchased in the open market a total of 2,032,000 Shares for an aggregate consideration of approximately HK$12,677,000 at an average price of HK$6.24 per Share from 16 April 2021 to 19 April 2021 ("Dr. Au-Yeung'sIncrease in Shareholding"), in addition to his purchase of 5,112,000 Shares from 15 January 2021 to 22 February 2021.

Immediately before Dr. Au-Yeung's Increase in Shareholding, Dr. Au-Yeung was interested in an aggregate of 875,656,896 Shares (of which 80,074,568 Shares held as beneficial owner and 795,582,328 Shares held through interest of controlled corporation), representing approximately 71.60% of the issued share capital of the Company.

Immediately after Dr. Au-Yeung's Increase in Shareholding, Dr. Au-Yeung is interested in an aggregate of 877,688,896 Shares (of which 82,106,568 Shares held as beneficial owner and 795,582,328 Shares held through interest of controlled corporation), representing approximately 71.77% of the issued share capital of the Company.

- 1 -

Dr. Au-Yeung is confident about the future prospects of the Company and may consider further increasing his shareholding in the Company when appropriate in the future, subject to compliance with applicable legal and regulatory requirements.

Based on the information available to the Company and to the knowledge of the Board as at the date of this announcement, the Company has maintained sufficient public float of the issued shares of the Company following the abovesaid increase in shareholding by Dr. Au-Yeung.

Shareholders and potential investors of the Company are cautioned not to unduly rely on such data and are advised to exercise caution when dealing in the shares of the Company.

By order of the Board

Perfect Shape Medical Limited

So Hin Lung

Company Secretary

Hong Kong, 20 April 2021

As at the date of this announcement, the Board comprises Dr. Au-Yeung Kong, Ms. Au-Yeung Wai and Ms. Au-Yeung Hung as executive Directors and Ms. Hsu Wai Man, Helen, Ms. Cho Yi Ping and Mr. Chi Chi Hung, Kenneth as independent non-executive Directors.

- 2 -

Attachments

  • Original document
  • Permalink

Disclaimer

Perfect Shape Beauty Technology Limited published this content on 20 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2021 06:57:08 UTC.